Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6189)	11/2/1998 6:10:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Big News: The date for the Celebrex FDA Advisory Committee is set. BigKNY3 ARTHRITIS ADVISORY COMMITTEE December 1, 1998, 8 a.m. to 5 p.m., and December 2, 1998, 8 a.m. to 4 p.m., Town Center Hotel, The Maryland Ballroom, 8727 Colesville Rd., Silver Spring, MD. ADDITIONAL INFORMATION:: Kathleen Reedy or LaNise Giles, Center for Drug Evaluation and Research (HFD-21), 301-827-7001. Oral presentations from the public will be scheduled between approximately 11 a.m. and 12 m. AGENDA: The Committee will discuss new drug application (NDA) 20-998 Celebrex™ (celecoxib, Searle) for the treatment of acute or chronic signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of pain.